BrUOG 302:BYL719, Capecitabine and Radiation for Rectal Cancer: A Brown University Oncology Research Group Study
Phase 1
Terminated
- Conditions
- Rectal Cancer
- Interventions
- First Posted Date
- 2015-09-15
- Last Posted Date
- 2021-03-12
- Lead Sponsor
- howard safran
- Target Recruit Count
- 7
- Registration Number
- NCT02550743
- Locations
- 🇺🇸
Rhode Island Hospital and The Miriam Hospital, Providence, Rhode Island, United States
Advanced Non-Small Cell Lung Cancer Progressing After at Least One Prior Therapy For Metastatic Disease
Phase 2
Terminated
- Conditions
- Non-small Cell Lung CancerMetastatic Lung CancerNSCLCLung Cancer
- Interventions
- First Posted Date
- 2015-06-11
- Last Posted Date
- 2020-02-17
- Lead Sponsor
- howard safran
- Target Recruit Count
- 10
- Registration Number
- NCT02469701
- Locations
- 🇺🇸
The Miriam Hospital, Providence, Rhode Island, United States
🇺🇸Rhode Island Hospital, Providence, Rhode Island, United States
A Dose Finding Study of Eribulin Mesylate and Cetuximab For Patients With Advanced Head and Neck and Colon Cancer
Phase 1
Completed
- Conditions
- Head and Neck CancerColon Cancer
- Interventions
- Drug: Head and neckDrug: Colon- Closed as of May 2014
- First Posted Date
- 2012-12-06
- Last Posted Date
- 2020-02-17
- Lead Sponsor
- howard safran
- Target Recruit Count
- 23
- Registration Number
- NCT01744340
- Locations
- 🇺🇸
Montefiore, Bronx, New York, United States
🇺🇸Memorial Hospital, Pawtucket, Rhode Island, United States
🇺🇸The Miriam Hospital, Providence, Rhode Island, United States
Chemotherapy for Patients With Gastroesophageal Cancers Who Have Progressed After One Prior Chemo Regimen
Phase 2
Terminated
- Conditions
- Gastric CancerGastrooesophageal CancerEsophageal
- Interventions
- First Posted Date
- 2011-06-03
- Last Posted Date
- 2019-04-12
- Lead Sponsor
- howard safran
- Target Recruit Count
- 15
- Registration Number
- NCT01365130
- Locations
- 🇺🇸
Memorial Hospital, Pawtucket, Rhode Island, United States
🇺🇸Brown University Oncology Research Group, Providence, Rhode Island, United States
🇺🇸Roger Williams, Providence, Rhode Island, United States
RAD001, Cisplatin and Concurrent Radiation for Locally Advanced, Inoperable Head and Neck Cancer
Phase 1
Terminated
- Conditions
- Head and Neck Cancer
- Interventions
- Drug: RAD001(Afinitor)
- First Posted Date
- 2010-01-27
- Last Posted Date
- 2020-02-17
- Lead Sponsor
- howard safran
- Target Recruit Count
- 3
- Registration Number
- NCT01057277
- Locations
- 🇺🇸
Rhode Island Hospital, Providence, Rhode Island, United States
PPX, Temozolomide, and Concurrent Radiation for Newly Diagnosed Brain Tumors
Phase 2
Completed
- Conditions
- Brain Tumor
- Interventions
- Drug: PPX +TMZ+XRT
- First Posted Date
- 2008-10-01
- Last Posted Date
- 2020-02-17
- Lead Sponsor
- howard safran
- Target Recruit Count
- 25
- Registration Number
- NCT00763750
- Locations
- 🇺🇸
Lifespan Hospitals, Providence, Rhode Island, United States
© Copyright 2025. All Rights Reserved by MedPath